Abiopharma

News list

Mock James M 🟡 adjusted position in 703 shares (1 derivative) of Moderna, Inc. (MRNA) at $50.03 Transaction Date: Apr 02, 2026 | Filing ID: 000053

Full text

News bot April 6, 2026, 8:46 p.m.
🔍 Mock James M (Executive)

Company: Moderna, Inc. (MRNA)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,453
- Total shares sold: 2,156
Detailed Transactions and Holdings:
- Acquired 1,453 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 58,451.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 703 shares of Common Stock at $50.03 per share (Direct)
  Date: 2026-04-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 57,748.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 1,453 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,906.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3
Footnotes:
- F1: Restricted stock units convert into common stock on a one-for-one basis.
- F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.